Why Should You Put Agenus Inc (NASDAQ: AGEN) On Your Portfolio?

Currently, there are 418.92M common shares owned by the public and among those 396.26M shares have been available to trade.

The company’s stock has a 5-day price change of 7.58% and -27.47% over the past three months. AGEN shares are trading -29.04% year to date (YTD), with the 12-month market performance down to -61.62% lower. It has a 12-month low price of $0.49 and touched a high of $2.13 over the same period. AGEN has an average intraday trading volume of 10.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.79%, -9.71%, and -42.64% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Agenus Inc (NASDAQ: AGEN) shares accounts for 54.83% of the company’s 418.92M shares outstanding.

It has a market capitalization of $246.12M and a beta (3y monthly) value of 1.26. The earnings-per-share (ttm) stands at -$0.69. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.96% over the week and 8.88% over the month.

Analysts forecast that Agenus Inc (AGEN) will achieve an EPS of -$0.15 for the current quarter, -$0.08 for the next quarter and -$0.69 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.21 while analysts give the company a high EPS estimate of -$0.08. Comparatively, EPS for the current quarter was -$0.22 a year ago. Earnings per share for the fiscal year are expected to increase by 40.87%, and -68.63% over the next financial year.

Looking at the support for the AGEN, a number of firms have released research notes about the stock. Robert W. Baird stated their Outperform rating for the stock in a research note on June 06, 2023, with the firm’s price target at $8. Robert W. Baird coverage for the Agenus Inc (AGEN) stock in a research note released on June 06, 2023 offered a Outperform rating with a price target of $80. H.C. Wainwright was of a view on February 28, 2023 that the stock is Buy, while SMBC Nikko gave the stock Outperform rating on September 28, 2022, issuing a price target of $5. H.C. Wainwright on their part issued Buy rating on December 16, 2021.

Most Popular

Related Posts